LDL Cholesterol Medicine: New Pill May Help Slash Bad Cholesterol — CAAS INDIA NEWS

A Ray of Hope for Heart Patients with the New Enlicitide Pill

New Delhi : A major update about LDL cholesterol medicine is bringing hope to millions fighting heart disease. Today, heart issues aren’t limited to older people, young adults are increasingly affected as well.

The main culprit is bad cholesterol, or LDL (Low-Density Lipoprotein), which raises the risk of heart attacks and strokes.

Recently, a new pill called Enlicitide has gained attention for reducing LDL by nearly 60% in 24 weeks, according to studies led by Merck & Co. (MSD) in the US, especially by Merck Research Laboratories’ Cardiology/Lipid Research group.

While expectations are high, experts are closely monitoring Enlicitide’s next steps, awaiting more data.

What Is Enlicitide and How Does It Work?

Heart disease often stems from LDL (bad cholesterol) accumulating in the arteries, leading to blockages and restricted blood flow. This raises the risk of heart attacks, strokes, and high blood pressure. That’s why LDL cholesterol medicine is crucial.

Enlicitide was developed specifically for this challenge. This medicine blocks a protein in the body called PCSK9, which normally reduces the liver’s ability to clear LDL cholesterol.

When PCSK9 is active, LDL builds up faster; however, Enlicitide halts PCSK9, letting the body eliminate more LDL efficiently. The result is a significant drop in bad cholesterol, explaining why many experts see Enlicitide as a promising cholesterol medicine for the future.

Current Treatments: Limitations and the Promise of Enlicitide

Currently, two main options exist to control LDL: statins and PCSK9 injections. Most patients use statins, which typically lower cholesterol by 30–50%.

But many patients still need additional help to reach healthy levels, often requiring expensive and inconvenient injection-based therapies.

Enlicitide emerges as a simpler alternative since it’s a daily pill. Experts believe this drug will especially benefit patients who can’t tolerate injections or want an easier option.

“This drug could be a real relief for patients who are uncomfortable with injections. But it’s still unclear whether the benefits for heart attack risk reduction will mirror the rapid drop in LDL.”

Thus, Enlicitide could become an effective supportive LDL cholesterol medicine.

Read Full News

⚕️ Disclaimer

This article has been prepared based on verified medical reports, discussions with doctors, subject experts, and academic institutions. Every effort has been made by caasindia.in professional journalists to check, verify, and cross-reference the facts mentioned here.

The purpose of this article is to create awareness and provide reliable information to readers. All editorial and ethical guidelines have been carefully followed while preparing this content.

This article should not be treated as a substitute for professional medical advice, diagnosis, or treatment. Readers are strongly advised to consult their own doctor or healthcare provider for any questions related to personal health conditions.

Originally published at https://en.caasindia.in on November 24, 2025.